ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AMN vs ASTH // EV/EBITDA & P/E VALUATION

AMN Healthcare Services Inc (NYSE) VS. Astrana Health Inc. (NASDAQ) • 15-METRIC TALLY: AMN 4 — ASTH 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMN VS. ASTH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AMN ASTH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -7.20% 4.60% -11.80 ASTH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 27.3x — TIE /valuation <GO>
Free Cash Flow Yield 12.86% 5.75% +7.11 AMN /fcf-yield <GO>
Operating Margin -2.00% 2.50% -4.50 ASTH /operating-margins <GO>
Net Profit Margin -3.50% 0.80% -4.30 ASTH /net-margins <GO>
Revenue Growth (YoY) -8.50% 56.40% -64.90 ASTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.43% -0.43 ASTH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.76 2.54 +0.22 AMN /balance-sheet <GO>
Piotroski F-Score Quality 5/9 6/9 -1.00 ASTH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 75.9 46.7 +29.19 AMN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 63.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.82B $1.82B $1.5M AMN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AMN REV ASTH REV AMN GROSS % ASTH GROSS % AMN FCF ASTH FCF
FY 2025 $2.73B $3.18B 28.3% — $233.8M $104.5M
FY 2024 $2.98B $2.03B 30.8% — $239.5M $44.2M
FY 2023 $3.79B $1.39B — — $372.2M $68.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMN // BETA —
ASTH // BETA —